In response to 'Behind EUD'

By Mavroidis Panayiotis   Lind Bengt  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 610-614

Informa Healthcare

Access to resources Recommend Favorite

Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans

By Kim Yusung   Toméé Wolfgang A.  

Acta Oncologica, Vol. 47, Iss. 5, 2008-05 ,pp. : 906-916

Informa Healthcare

Access to resources Recommend Favorite

Behind [image omitted] : In Response to Drs. Mavroidis and Lind

By Wang Jian   Huang Zhibin   Mayr Nina   Yuh William  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 614-617

Informa Healthcare

Access to resources Recommend Favorite

Shortened telomeres: a driving force behind leukemia?

By Pepper Chris   Baird Duncan M  

Future Oncology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1681-1686

Future Medicine

Access to resources Recommend Favorite

Late neointimal tissue growth behind the stent after intravascular -radiation

By Busseuil D.   Zeller M.   Cottin Y.   Maingon P.   Barillot I.   Allouch P.   Ponnelle T.   Bril A.   Briot F.   Wolf J.-E.   Rochette L.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 259-266

Elsevier

Access to resources Recommend Favorite